PROBUCOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN HYPERCHOLESTEROLEMIA

被引：142

作者：

BUCKLEY, MMT

GOA, KL

PRICE, AH

BROGDEN, RN

机构：

来源：

DRUGS | 1989年 / 37卷 / 06期

关键词：

D O I：

10.2165/00003495-198937060-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：761 / 800

页数：40

相关论文

共 145 条

[11] BEAUMONT V, 1980, DIET DRUGS ATHEROSCL, P209
[12] INFLUENCE OF PROBUCOL ADMINISTRATION ON LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEINS IN NORMOLIPEMIC MALES
BERG, A
FREY, I
BAUMSTARK, M
KEUL, J
[J]. ATHEROSCLEROSIS, 1988, 72 (01) : 49 - 54
[13] BERG A, 1988, 8 INT S ATH ROM
[14] BERTOLINI S, 1983, IRCS MED SCI-BIOCHEM, V11, P933
[15] DISCREPANCIES BETWEEN THE OUTCOME OF ANIMAL AND HUMAN STUDIES ON THE MODE OF ACTION OF PROBUCOL
BEYNEN, AC
[J]. ATHEROSCLEROSIS, 1986, 61 (03) : 249 - 251
[16] BOYDEN TW, 1981, J CLIN PHARMACOL, V1, P48
[17] PROLONGATION OF THE QT INTERVAL INDUCED BY PROBUCOL - DEMONSTRATION OF A METHOD FOR DETERMINING QT INTERVAL CHANGE INDUCED BY A DRUG
BROWNE, KF
PRYSTOWSKY, EN
HEGER, JJ
CERIMELE, BJ
FINEBERG, N
ZIPES, DP
[J]. AMERICAN HEART JOURNAL, 1984, 107 (04) : 680 - 684
[18] BUXTORF JC, 1985, SEM HOP PARIS, V61, P837
[19] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT
CAREW, TE
SCHWENKE, DC
STEINBERG, D
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7725 - 7729
[20] CARMENA R, 1980, DIET DRUGS ATHEROSCL, P215

← 1 2 3 4 5 6 7 8 9 10 →